ProHance 279.3 mg/mL (Gadoteridol INJECTION, SOLUTION) 279.3 mg/mL

ProHance 279.3 mg/mL is a gadoteridol injection used for contrast enhancement in MRI scans. This single-dose solution is designed for intravenous administration, providing clear imaging for diagnostic purposes.

Strength

279.3 mg/mL

Pack Size

5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) / 15 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ProHance 279.3 mg/mL is primarily used as a contrast agent to enhance the visibility of internal structures during magnetic resonance imaging (MRI). It helps in identifying abnormalities and improving the clarity of images, making it easier for healthcare professionals to diagnose various conditions. This gadoteridol injection is commonly used in what is ProHance used for scenarios involving detailed imaging of organs and tissues.

Side Effects

When administered intravenously, ProHance 279.3 mg/mL works by temporarily altering the magnetic properties of tissues, which enhances the contrast in MRI images. This can lead to clearer and more detailed visuals, aiding in the detection of abnormalities. The effects are typically short-lived, focusing on improving the quality of diagnostic imaging.

Precautions & Warnings

ProHance 279.3 mg/mL should be handled with care, ensuring it is stored and administered under proper medical supervision. It is important to follow standard protocols for intravenous injections to minimize the risk of complications. Patients with known allergies to gadoteridol or similar contrast agents should exercise caution.

Avoid Interactions

ProHance 279.3 mg/mL may interact with certain medications or medical conditions. It is advisable to inform healthcare providers about any ongoing treatments or allergies before administration. Specific interactions with other contrast agents or medications should be discussed with a healthcare professional.

Frequently Asked Questions

ProHance 279.3 mg/mL is used as a contrast agent to enhance the visibility of internal structures during MRI scans, aiding in the diagnosis of various conditions.

ProHance 279.3 mg/mL is administered intravenously by healthcare professionals during MRI procedures.

ProHance 279.3 mg/mL enhances the contrast in MRI images, providing clearer and more detailed visuals of internal structures.

ProHance 279.3 mg/mL should be administered under medical supervision, and patients with allergies to gadoteridol should exercise caution.

ProHance 279.3 mg/mL may interact with certain medications or medical conditions, so it is important to inform healthcare providers about any ongoing treatments.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.